Бизнес · 20.07.20181 мин чтения
Metered Dose Inhaler and Dry Powder Inhaler Drug Products-Quality Considerations; Draft Guidance for Industry; Reopening of the Comment Period
Локальный автоматический перевод · Язык оригинального источника
Краткое содержание
The Food and Drug Administration (FDA, Agency, or we) is reopening the comment period for the "Metered Dose Inhaler and Dry Powder Inhaler Drug Products--Quality Considerations; Draft Guidance for Industry," published in the Federal Register of April 19, 2018. FDA is reopening the comment period to allow interested persons additional time to submit comments.